Australia markets open in 4 hours 54 minutes

Aclaris Therapeutics, Inc. (8AT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.0540-0.0525 (-4.74%)
As of 08:04AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6666
Avg. Estimate-0.28-0.37-1.54-1.46
Low estimate-0.35-0.69-1.95-2
High estimate-0.2-0.21-1.27-1.13
Year ago EPS-0.25-0.3-1.2-1.54
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6666
Avg. Estimate1.77M1.78M7.17M7.6M
Low estimate1.5M1.4M6.5M6.5M
High estimate2M2.1M7.7M8.9M
Year ago sales1.45M1.58M6.48M7.17M
Sales growth (year/est)22.20%12.70%10.60%6.00%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.3-0.27-0.29-0.28
Actual EPS-0.25-0.3-0.57-0.34
Difference0.05-0.03-0.28-0.06
Surprise %16.70%-11.10%-96.60%-21.40%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.28-0.37-1.54-1.46
7 days ago-0.28-0.37-1.54-1.46
30 days ago-0.28-0.37-1.54-1.46
60 days ago-0.27-0.3-1.33-1.25
90 days ago-0.3-0.33-1.34-1.32
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates8AT.FIndustrySector(s)S&P 500
Current qtr.-12.00%N/AN/AN/A
Next qtr.-23.30%N/AN/AN/A
Current year-28.30%N/AN/AN/A
Next year5.20%N/AN/AN/A
Next 5 years (per annum)74.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A